Diana Karpman
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Cellular signaling pathway of Shiga toxin-induced ATP release.
Journal: Frontiers in cellular and infection microbiology
Published: September 14, 2025
Heme-induced kallikrein-kinin system activation in hemolytic uremic syndrome.
Journal: Kidney international
Published: February 26, 2025
Angiotensinogen and C3 compete for renin-induced complement activation.
Journal: Frontiers in immunology
Published: January 20, 2025
Bradykinin B1 receptor signaling triggers complement activation on endothelial cells.
Journal: Frontiers in immunology
Published: November 12, 2024
Corrigendum: Genetic investigation of Nordic patients with complement-mediated kidney diseases.
Journal: Frontiers in immunology
Published: August 05, 2024
Hypoaldosteronism due to a novel SEC61A1 variant successfully treated with fludrocortisone.
Journal: Clinical kidney journal
Published: March 19, 2024
Red blood cell-derived arginase release in hemolytic uremic syndrome.
Journal: Journal of translational medicine
Published: August 29, 2023
Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome.
Journal: Pediatric nephrology (Berlin, Germany)
Published: July 25, 2023
Genetic investigation of Nordic patients with complement-mediated kidney diseases.
Journal: Frontiers in immunology
Published: July 07, 2023
Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome.
Journal: Kidney international reports
Published: November 15, 2022
In Vivo Sustained Release of the Retrograde Transport Inhibitor Retro-2.1 Formulated in a Thermosensitive Hydrogel.
Journal: International journal of molecular sciences
Published: October 29, 2022
Last Updated: 09/26/2026